PFC Lab Director Presents at Fertility 2013 in Liverpool, England
On Thursday, January 3, Joseph Conaghan, PhD, Pacific Fertility Center's lab director, will present a scientific session in Liverpool, England on time-lapse embryo imaging at Fertility 2013, the 8th biennial three-day conference of the UK Fertility Societies. Called Eeva, the non-invasive technique allows for accurate identification of healthy embryos for transfer at an earlier developmental stage than traditional methods.
Time-lapse embryo imaging takes photos of embryos at set intervals, stitching them together into a time-lapse video. Combined with a computer software program, the technique enables embryologists to predict blastocyst formation and select the most viable embryo(s) for implantation by closely monitoring timelines of cell division.
These novel measures of viability have the potential to improve pregnancy rates and may be pivotal to the success of single embryo transfer, which reduces multiple births and the risks associated with them.
Dr. Conaghan also presented on time-lapse embryo imaging at the Fertility Society of Australia (FSA) 2012 Annual Scientific Meeting in Auckland, New Zealand, where he won an award for the Best Scientific Paper. It was entitled "Embryos with Good Morphology but Abnormal Cell Divisions have Significantly Lower Implantation Potential." With more than two decades of experience in human embryology, Dr. Conaghan may be best known for his studies on embryo culture and metabolism.
Sponsored by the Association of Clinical Embryologists, the British Fertility Society, and the Society for Reproduction and Fertility, Fertility 2013 features more than 200 poster presentations, a large trade exhibition, and a wide range of plenary and concurrent sessions attended by more than 400 experts in fertility, assisted conception, sexual health, and reproductive biology.
Pacific Fertility Center is an international destination for male and female fertility treatment and care. It provides an extensive array of fertility treatment options ranging from intrauterine insemination (IUI), intracytoplasmic sperm injection (ICSI) and in vitro fertilization (IVF) to cutting-edge technology such as vitrification and genetic testing of embryos.